ANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets

BAUDETTE, Minn., July 6, 2020 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the acquisition of Fluconazole Tablets USP, 50mg, 100mg, 150mg, and 200mg from a private company for $3.0... Biopharmaceuticals, Acquisitions ANI Pharmaceuticals, Fluconazole, candidiasis, candida
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news